aid: alpheus-medical

name: Alpheus Medical

image: https://alpheusmedical.com/wp-content/uploads/alpheus-medical-facebook-og-scaled.jpg

description: 'Alpheus Medical is a private, clinical-stage biotechnology company developing Porphyrin Metabolite Activation (PoMA™), a drug-led, tumor-selective oncology approach using low‑intensity ultrasound to activate a tumor‑accumulating drug, currently in Phase 2b trials for glioblastoma. The therapy aims to improve outcomes while reducing treatment burden for patients and families.'

url: https://raw.githubusercontent.com/api-evangelist/alpheus-medical/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-05 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-09-24'

modified: '2026-09-24'

tags:
- Biotechnology
- Oncology
- Medical Devices
- Clinical Trials
- Company

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: LLMsTxt
  url: llms/alpheus-medical-llms.txt
- type: Hosts
  url: hosts/alpheus-medical-hosts.yml
- type: Vendors
  url: vendors/alpheus-medical-vendors.yml
- type: TermsOfService
  url: https://alpheusmedical.com/terms-of-use/
- type: PrivacyPolicy
  url: https://alpheusmedical.com/privacy-policy/
- type: Newsroom
  url: https://alpheusmedical.com/news/
- type: DomainSecurity
  url: security/alpheus-medical-domain-security.yml
- type: Website
  url: https://alpheusmedical.com/

apis: []

x-coverage:
  state: unreadable
  reason: no-machine-readable-spec
  detail: The API host https://api.alpheusmedical.com returns no response, providing no machine‑readable specification.
  evidence:
    - url: https://api.alpheusmedical.com
      status: 000
  checked: '2026-10-05'
x-enrichment:
  date: '2026-10-05'
  status: enriched
  artifacts_added: 9
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local